Wedbush Maintains Neutral on Sionna Therapeutics, Raises Price Target to $6

Benzinga · 3d ago
Wedbush analyst Laura Chico maintains Sionna Therapeutics (NASDAQ:SION) with a Neutral and raises the price target from $5 to $6.